Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 1 Open-Label, Dose Escalation Study to Assess the Safety and Tolerability of Intravitreal ONL1204 in Patients With Macula-off, Rhegmatogenous Retinal Detachment

Next Previous
Trial Profile

A Phase 1 Open-Label, Dose Escalation Study to Assess the Safety and Tolerability of Intravitreal ONL1204 in Patients With Macula-off, Rhegmatogenous Retinal Detachment

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 26 Sep 2024

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs ONL 1204 (Primary)
  • Indications Retinal detachment
  • Focus Adverse reactions; First in man; Therapeutic Use
  • Sponsors ONL Therapeutics

Most Recent Events

  • 11 Apr 2023 According to an ONL Therapeutics media release, the company will deliver a podium presentation reviewing the results from this study at the upcoming annual meeting of the Association for Research in Vision and Ophthalmology (ARVO).
  • 07 Oct 2022 Status changed from active, no longer recruiting to completed.
  • 12 Jul 2022 According to an AmbioPharm media release, enrollment has been completed in this study.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top